SCHEMBL16645310

SCHEMBL16645310

O=c1[nH]c(-c2ccc(I)cc2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.57
RARB P10826 2/20 0.53
ADH5 P11766 1/20 0.51
ALOX5 P09917 1/20 0.49
XDH P47989 2/20 0.46
SLC22A12 Q96S37 1/20 0.46
PARP1 P09874 1/20 0.46
RARG P13631 1/20 0.45
PLA2G2A P14555 4/20 0.44
KMO O15229 1/20 0.43
CDC7 O00311 1/20 0.43
PLK4 O00444 1/20 0.43
AURKA O14965 1/20 0.43
MAPK13 O15264 1/20 0.43
DAPK3 O43293 1/20 0.43
DYRK3 O43781 1/20 0.43
ROCK2 O75116 1/20 0.43
RPS6KA5 O75582 1/20 0.43
MAP4K4 O95819 1/20 0.43
CDK1 P06493 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2646011 0.82 ALDH1A1 (0.58) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL4443620 0.81 ALDH1A1 (0.57) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL15059787 0.81 ALDH1A1 (0.57) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL22273714 0.81 ALOX5 (0.63) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL2963261 0.81 ALDH1A1 (0.61) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL18603158 0.81 ALDH1A1 (0.57) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL2646013 0.81 ALDH1A1 (0.57) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL750501 0.81 ALDH1A1 (0.57) ALDH1A1RARBADH5ALOX5XDH
SCHEMBL3743779 0.80 ALDH1A1 (0.56) ALDH1A1RARBADH5ALOX5XDH
Hydrochloric Acid SCHEMBL12803102 0.79 ALDH1A1 (0.55) ALDH1A1RARBADH5ALOX5XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313967-B1 KHK INHIBITORS GILEAD SCIENCES INC (US) 2025-11-12 EP disclosed
US-12410160-B2 KHK inhibitors GILEAD SCIENCES, INC. (US) 2025-09-09 US disclosed
EP-4313967-A1 KHK INHIBITORS GILEAD SCIENCES, INC. (US) 2024-02-07 EP disclosed
CN-117120429-A KHK inhibitor 吉利德科学公司 2023-11-24 CN disclosed
US-20230079863-A1 KHK INHIBITORS GILEAD SCIENCES, INC. 2023-03-16 US disclosed
WO-2022212194-A1 KHK INHIBITORS GILEAD SCIENCES, INC. (US) 2022-10-06 WO disclosed
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079863-A1 KHK INHIBITORS KHK, KHDRBS1, NADK ALDH1A1 1520/4885RARB 3604/4885ADH5 972/4885
US-12410160-B2 KHK inhibitors KHK, KHDRBS1, NADK ALDH1A1 1520/4885RARB 3604/4885ADH5 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.